SCHEDULE 13G

Company

Altimmune, Inc.

Filed

June 25, 2020

Accession Number

0001104659-20-076855

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →